Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics

Julie A. Ribes, Angela Smith, Marie Hayes, Doris J. Baker, Jeffrey L. Winters

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Two companies, MRL and Meridian Diagnostics, have developed Food and Drug Administration-approved herpes simplex virus type 1 type-specific enzyme immunoassays. The sensitivity, specificity, and overall testing efficiency of these assays were 98.2, 93.8, and 96.6% for MRL and 98.8, 99.0, and 98.1% for Meridian, making both of these kits suitable for use in the clinical lab.

Original languageEnglish
Pages (from-to)1071-1072
Number of pages2
JournalJournal of Clinical Microbiology
Volume40
Issue number3
DOIs
StatePublished - 2002

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics'. Together they form a unique fingerprint.

Cite this